Replies to post #88326 on Innovation Pharmaceuticals Inc (IPIX)

[daydreaming2]

Probably don't get it because he is actually a she... and your not a level 4 cancer patient facing death. Counting on your doctor to lead you in the right direction... as the Dr. said in the conference presentation it was an example of treating symptoms and not the patient!

Pretty simple, no?

GLTA

[Tails]

From the PR:

"The idea that a stage 4 ovarian cancer patient’s disease was clinically stabilized, although her CA-125 count was increased in the third month, is remarkable. The patients in our trial are incredibly sick, have often run the gamut of approved treatments and subject to constant therapy modification to address the greatest area of need at the given moment. That’s an everyday practice in oncology, especially when a drug regimen, such as the strict protocol with the Kevetrin trial where dosing levels and intervals absolutely cannot be changed. We are not privy to the minutiae underscoring any physician’s decisions in a trial, but we interpret the stabilization of the cancer as allotting the physician an opportunity to modify treatment to improve the patient’s quality of life, an opportunity that potentially may have not been there without Kevetrin."

I take that to mean the oncologist was managing the many issues of the patient to provide the best outcome over the short term. Quality of life at the end of the road. An unknowable for us and CTIX as the specifics.

Nothing to do with K that might be construed as negative.

[alwaysdreaming]

CTIX up over a buck today and nearly 3 mil shares traded, perhaps you are one of the Few who don't get it.

My dad used to have a saying when we went hunting, "shoot now and we can sort them out later", perhaps you should be buying now and asking questions later, because the PPS will not wait for you to figure out the details of the PR.

GLTU!

[muelch]

A lot of treatments work at first, but then stop and the cancer becomes resistant.

It can be argued that could have been the case here, with cycle two showing an improvement, but then cycle 3 showing potential resistance developing (ie no improvement and tumor marker increasing).

It's not an easy choice, this may just have been an aggressive dr/patient wanting to rapidly move on to the next treatment, which is done all of the time.

And who are we to say they're wrong?